Antineoplastic Agents, Immunological Concept

Vocabulary Service

MeSH

Overview

subject area of

A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignancies Conference Paper
Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature Academic Article
Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety? Academic Article
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial Academic Article
Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma Academic Article
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium Academic Article
Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non–Small Cell Lung Cancer Academic Article
Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis Academic Article
Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events Academic Article
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Academic Article
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study Academic Article
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma Academic Article
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12^* Academic Article
Evaluation of Subcutaneous Rituximab Administration on Canadian Systemic Therapy Suites Academic Article
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP) Academic Article
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors Academic Article
Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review Academic Article
Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer Academic Article
Immunotherapy in the Elderly Academic Article
Immunotherapy with check-point inhibitors (CPI) in adult malignancies: a protocol for the systematic review of the quality of economic analyses Academic Article
Longitudinal High-Sensitivity Cardiac Troponin I Measurements in Patients With Breast Cancer Receiving Trastuzumab Academic Article
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial Academic Article
Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003–2013 Academic Article
Preliminary Investigation of Focused Ultrasound-Facilitated Drug Delivery for the Treatment of Leptomeningeal Metastases Academic Article
Real-World Benefit of Nivolumab in A Canadian Non-Small-Cell Lung Cancer Cohort Academic Article
Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis Academic Article
Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review Academic Article
Targeted therapy for metastatic renal cell carcinoma Academic Article
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma Academic Article
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER? Academic Article